Health News - Towards personalised cancer treatment

Health News - Towards personalised cancer treatment

 ".....“Unfortunately, there are so many different mutations in the tumour cells that clones arise that do not respond to the medication. These clones eventually gain the upper hand and the effect of the medication diminishes over time,” he adds. In some cases second line treatment is available, in others a new mutation profile may reveal more options......

“Unfortunately, there are so many different mutations in the tumour cells that clones arise that do not respond to the medication. These clones eventually gain the upper hand and the effect of the medication diminishes over time,” he adds. In some cases second line treatment is available, in others a new mutation profile may reveal more options. - See more at: http://www.healthcanal.com/cancers/36607-Towards-personalised-cancer-treatment.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+healthnewshc%2FOxfp+%28Health+News+from+HealthCanal.com%29&utm_content=Google+Reader#sthash.1rCgcsZn.dpuf

“Unfortunately, there are so many different mutations in the tumour cells that clones arise that do not respond to the medication. These clones eventually gain the upper hand and the effect of the medication diminishes over time,” he adds. In some cases second line treatment is available, in others a new mutation profile may reveal more options. - See more at: http://www.healthcanal.com/cancers/36607-Towards-personalised-cancer-treatment.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+healthnewshc%2FOxfp+%28Health+News+from+HealthCanal.com%29&utm_content=Google+Reader#sthash.1rCgcsZn.dpuf

“Unfortunately, there are so many different mutations in the tumour cells that clones arise that do not respond to the medication. These clones eventually gain the upper hand and the effect of the medication diminishes over time,” he adds. In some cases second line treatment is available, in others a new mutation profile may reveal more options. - See more at: http://www.healthcanal.com/cancers/36607-Towards-personalised-cancer-treatment.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+healthnewshc%2FOxfp+%28Health+News+from+HealthCanal.com%29&utm_content=Google+Reader#sthash.1rCgcsZn.dpuf

“Unfortunately, there are so many different mutations in the tumour cells that clones arise that do not respond to the medication. These clones eventually gain the upper hand and the effect of the medication diminishes over time,” he adds. In some cases second line treatment is available, in others a new mutation profile may reveal more options. - See more at: http://www.healthcanal.com/cancers/36607-Towards-personalised-cancer-treatment.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+healthnewshc%2FOxfp+%28Health+News+from+HealthCanal.com%29&utm_content=Google+Reader#sthash.1rCgcsZn.dpuf